Main Management ETF Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-792,750	Closed	-$60.4M	–	40
2023 Q1	$60.4M	Buy	792,750 +21,140	+3%	+$1.75M	5.13%	10
2022 Q4	$64M	Buy	771,610 +295,865	+62%	+$24M	5.98%	8
2022 Q3	$37.7M	Buy	475,745 +3,860	+0.8%	+$325K	4.33%	11
2022 Q2	$35M	Sell	471,885 -965	-0.2%	-$72.4K	3.89%	11
2022 Q1	$42.5M	Buy	472,850 +297,530	+170%	+$27.5M	3.95%	11
2021 Q4	$19.6M	Buy	175,320 +9,000	+5%	+$1.09M	1.72%	15
2021 Q3	$20.9M	Buy	166,320 +7,560	+5%	+$974K	2.11%	15
2021 Q2	$21.5M	Buy	158,760 +8,280	+6%	+$1.09M	2.24%	15
2021 Q1	$20.4M	Sell	150,480 -53,570	-26%	-$8.02M	2.41%	15
2020 Q4	$28.7M	Sell	204,050 -550	-0.3%	-$70.4K	4.5%	12
2020 Q3	$22.8M	Sell	204,600 -5,500	-3%	-$617K	4.02%	11
2020 Q2	$23.5M	Buy	210,100 +9,350	+5%	+$921K	4.44%	11
2020 Q1	$15.5M	Sell	200,750 -550	-0.3%	-$48.7K	3.72%	10
2019 Q4	$19.1M	Buy	201,300 +8,800	+5%	+$761K	3.71%	11
2019 Q3	$14.7M	Sell	192,500 -107,200	-36%	-$8.91M	3.19%	11
2019 Q2	$26.3M	Buy	299,700 +18,000	+6%	+$1.54M	6.06%	7
2019 Q1	$25.5M	Buy	281,700 +15,300	+6%	+$1.3M	5.92%	7
2018 Q4	$19.1M	Buy	266,400 +15,300	+6%	+$1.23M	5.34%	7
2018 Q3	$24.1M	Buy	251,100 +29,700	+13%	+$2.88M	6.06%	7
2018 Q2	$21.1M	Buy	221,400 +33,300	+18%	+$3.06M	6.27%	7
2018 Q1	$16.5M	Buy	188,100 +30,600	+19%	+$2.79M	5.85%	7
2017 Q4	$13.4M	Buy	+157,500	New	+$13.2M	5.72%	7